The patch is hard to find. Estradiol is not. Here is your actual plan.
If you are reading this after a second pharmacy call, you already know the situation: estradiol patches, especially the twice-weekly form, have become genuinely hard to fill in much of the country. Demand for menopause hormone therapy has surged past what patch manufacturers are producing. Here is the part the panic misses: the scarce thing is one delivery format, not the hormone. Estradiol itself remains available in several forms, including the transdermal gel that works through the skin the same way your patch does. A licensed clinician can review your case online and, where it fits, move your therapy to a form you can actually fill.
The short answer
Do not stop your therapy abruptly, and do not start rationing patches on your own; both are decisions that deserve a clinician, not a guess. The fastest stable answer for most patch patients is a change of form rather than a change of plan: transdermal estradiol gel delivers the same hormone through the same route, applied daily instead of twice weekly. Oral tablets are an option where your health history supports them, and if your symptoms are mainly local, a vaginal cream may be the better tool than any systemic form. Start the Assessment, tell us what you were on, and a licensed clinician takes it from there. Reviews are typically completed in under 24 hours.
What is actually going on
Reporting through the summer describes pharmacies and patients across the country struggling to fill patch prescriptions, and manufacturers acknowledging that demand has outpaced supply. The demand story is real and, frankly, good news: more women are seeking menopause care, more clinicians are comfortable prescribing hormone therapy, and the FDA's removal of the boxed warning from estrogen products has changed the conversation. The supply side has not caught up. The FDA, for its part, has not declared a formal shortage, which is why your pharmacist may be telling you something different from what the government database says. Both are describing the same moment from different chairs.
Your options, in the order a clinician usually thinks about them
The gel. Transdermal, like your patch: estradiol through the skin, bypassing the liver's first pass, which is the property that made the patch the clinical default in the first place. Applied daily rather than changed twice weekly. For most patch patients asking "what is closest to what I had," this is the answer.
The tablet. Oral estradiol is the simplest routine and the form where your health history matters most, because oral estrogen is processed through the liver first. That is a real clinical consideration, not a formality, and it is exactly what the review weighs.
The vaginal cream. If your symptoms are primarily local rather than systemic, low-dose local treatment may be the better tool regardless of any shortage. Worth naming honestly: some women on systemic therapy discover in review that local treatment was the better fit all along.
Compounded patches. We also prescribe estradiol patches, compounded to your individual prescription by a licensed US pharmacy after clinician review. They are part of the catalogue, not a shortage workaround, and like every compounded medication they are not FDA-approved. Whether any of these four fits your case is the clinician's call, made against your history.
Every systemic option above still follows the standard rule: if you have a uterus, systemic estrogen is generally paired with progesterone, and your clinician addresses that as part of the plan.
If you are mid-gap right now
A short gap does not undo your therapy, but symptoms can return as levels fall, and how fast varies by person. Do not cut patches in half, stretch wear times, or borrow forms without guidance; bring the situation to a clinician instead, yours or ours. If you use the Assessment, say plainly that you are an existing patch patient facing a supply gap. That context changes how the review reads your case, and it is exactly the situation a clinician can move quickly on.
Questions
What happens if I am not approved?
You are not charged. Your clinician explains the reasoning and, where useful, what a better next step may be. Reviews are typically completed in under 24 hours.
Is switching from the patch to the gel a downgrade?
No. It is the same hormone through the same route with a different applicator and rhythm: daily instead of twice weekly. The adjustment that matters is habit, not biology, and your clinician will say if your case reads differently.
Are your products affected by the shortage?
Our estradiol therapies are compounded to individual prescriptions by a licensed US pharmacy, which is a different supply chain from the commercial patch manufacturers in the news. No compounded medication is FDA-approved, including these. Compounded medicines are made to your individual prescription by a licensed pharmacy rather than manufactured and approved as a finished drug product.
Will I need new labs to switch forms?
That is your clinician's call after reviewing your history and what you were taking. Arrive with your current prescription details and the review moves faster.
Which is right for me, patch, gel, or pill?
We wrote that comparison plainly: Estradiol Patch vs Gel vs Pill. The short version is that the route is a clinical decision, and the review exists to make it with you.
Ready when you are.
About 10 minutes. No charge unless your clinician approves.